What are the size ranges for adrenal incidentalomas in which further workup is recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Size Ranges for Adrenal Incidentaloma Requiring Further Workup

For adrenal incidentalomas, further workup is recommended for lesions ≥3 cm, with surgical consideration strongly indicated for masses >5 cm due to increased risk of malignancy. 1

Size-Based Management Algorithm

  • Lesions <3 cm with benign imaging characteristics (<10 HU on non-contrast CT) generally do not require extensive workup as most are benign adenomas 1, 2
  • Lesions 3-5 cm should undergo second-line imaging with either washout CT or chemical shift MRI to better characterize the mass 1, 3
  • Lesions >5 cm should be surgically removed due to significantly higher risk of malignancy 1, 2
  • Lesions ≥4 cm that are radiologically benign (<10 HU) should undergo repeat imaging in 6-12 months 1, 3

Imaging Characteristics That Warrant Further Evaluation

  • Adrenal masses >10 HU on non-contrast CT require additional imaging regardless of size 1, 3
  • Inhomogeneous appearance, irregular margins, and lack of clear boundaries are concerning features that warrant additional evaluation 2, 4
  • Growth rate >5 mm/year on follow-up imaging is an indication for surgical consideration after repeating functional workup 1, 3
  • Growth rate <3 mm/year does not require further imaging or functional testing 1, 3

Hormonal Evaluation

  • All adrenal incidentalomas, regardless of size, should undergo hormonal evaluation 3, 4:
    • 1 mg overnight dexamethasone suppression test to screen for autonomous cortisol secretion
    • Plasma or urinary metanephrines for pheochromocytoma (especially for lesions ≥10 HU)
    • Aldosterone/renin ratio for patients with hypertension and/or hypokalemia

Special Considerations

  • For patients with history of malignancy, even smaller adrenal lesions warrant closer evaluation as the risk of metastatic disease is significantly higher (25-72% depending on primary tumor type) 1, 4
  • Adrenal biopsy should be reserved only for cases where noninvasive techniques are equivocal and there is high suspicion for metastatic disease 1, 4

Common Pitfalls to Avoid

  • Relying solely on size criteria for determining malignancy risk - imaging characteristics and growth rate are also important 2, 5
  • Failing to perform hormonal evaluation on all adrenal incidentalomas, which can miss subclinical hormone production 3, 6
  • Unnecessary follow-up imaging for small (<3 cm) adrenal masses with benign characteristics, leading to increased radiation exposure and patient anxiety 2, 3
  • Over-reliance on adrenal washout CT, as approximately 1/3 of pheochromocytomas may washout in the characteristic range of an adenoma, and 1/3 of adrenal adenomas do not washout in the adenoma range 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Adrenal Incidentaloma with Minimal Growth

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Laboratory Tests for Adrenal Incidentaloma Follow-up

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Small Adrenal Adenomas

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adrenal incidentaloma.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.